Today it takes many years to translate scientific evidence from discovery into health care practice. Stakeholders are likely losing time, money, and opportunities to improve health outcomes, as well as chances to revive the global competitiveness of the US. In the recent Health Sciences Dbriefs webcast, Improving health outcomes: The future of medical research and development, we asked approximately 1,400 professionals for their views and opinions on the future of medical research and development (R&D).
Below is a snapshot of their responses. For more information on this webcast or to register for upcoming webcasts, please visit: www.deloitte.com/us/dbriefs/healthsciences
For more on the future of medical R&D, check out:Measuring the return from pharmaceutical innovation